This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vestbo, J. Articles by Lange, P. Search for Related Content PubMed PubMed Citation Articles by Vestbo, J. Articles by Lange, P.

Can GOLD Stage 0 Provide Information of Prognostic Value in Chronic Obstructive Pulmonary Disease?

Department of Respiratory Medicine, Hvidovre University Hospital, Hvidovre, Denmark

Correspondence and requests for reprints should be addressed to Dr. J. Vestbo, Department of Respiratory Medicine 223, Hvidovre University Hospital, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark. E-mail: joergen.vestbo{at}hh.hosp.dk

In the recently published guidelines of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for chronic obstructive pulmonary disease (COPD), the staging system included a Stage 0 for subjects without airways obstruction but with respiratory symptoms, denoting these subjects "at risk" for COPD. Our aim was to validate this staging approach using data from three surveys in The Copenhagen City Heart Study, in which a sample of the general population was examined at baseline and in which, after 5 and 15 years, spirometry was performed at all surveys. Criteria for GOLD Stage 0 was fulfilled by 5.8% of the total adult population and 7.2% of smokers. After 5 and 15 years, 13.2 and 20.5%, respectively, of smokers with GOLD Stage 0 had developed COPD fulfilling criteria for GOLD Stage 1 or worse. This was the case for 11.6 and 18.5%, respectively, of smokers without respiratory symptoms. Further analyses using multivariate logistic regression analysis confirmed that GOLD Stage 0 was not identifying subsequent airways obstruction. When analyzing FEV₁ decline, Stage 0 carried a risk of excess decline. GOLD Stage 0 was not a stable feature, which may explain the lack of predictive value. In the Western world, smoking is still in itself the most important indicator of risk of COPD, and alternative markers of susceptibility in the population must be investigated.

Key Words: COPD • epidemiology • guidelines • prognosis

This article has been cited by other articles:

				H. Kan, J. Stevens, G. Heiss, K. M. Rose, and S. J. London Dietary Fiber, Lung Function, and Chronic Obstructive Pulmonary Disease in the Atherosclerosis Risk in Communities Study Am. J. Epidemiol., March 1, 2008; 167(5): 570 - 578. [Abstract] [Full Text] [PDF]

				M Albers, T Schermer, Y Heijdra, J Molema, R Akkermans, and C van Weel Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease Thorax, March 1, 2008; 63(3): 201 - 207. [Abstract] [Full Text] [PDF]

				G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi Definition, epidemiology and natural history of COPD Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013. [Abstract] [Full Text] [PDF]

				D. M. Mannino and S. Braman The Epidemiology and Economics of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, October 1, 2007; 4(7): 502 - 506. [Abstract] [Full Text] [PDF]

				V. M. Pinto-Plata, R. A. Celli-Cruz, C. Vassaux, L. Torre-Bouscoulet, A. Mendes, J. Rassulo, and B. R. Celli Differences in Cardiopulmonary Exercise Test Results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease Stage Categories and Gender Chest, October 1, 2007; 132(4): 1204 - 1211. [Abstract] [Full Text] [PDF]

				N. Roche Where current pharmacological therapies fall short in COPD: symptom control is not enough Eur. Respir. Rev., September 1, 2007; 16(105): 98 - 104. [Abstract] [Full Text] [PDF]

				V. Brusasco, E. Crimi, and R. Pellegrino Airway Inflammation in COPD: Friend or Foe? Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 425 - 426. [Full Text] [PDF]

				J. Vestbo Chronic Cough and Phlegm in Young Adults: Should We Worry? Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 2 - 3. [Full Text] [PDF]

				V. L. Kinnula, H. Ilumets, M. Myllarniemi, A. Sovijarvi, and P. Rytila 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD Eur. Respir. J., January 1, 2007; 29(1): 51 - 55. [Abstract] [Full Text] [PDF]

				R. de Marco, S. Accordini, I. Cerveri, A. Corsico, J. M. Anto, N. Kunzli, C. Janson, J. Sunyer, D. Jarvis, S. Chinn, et al. Incidence of Chronic Obstructive Pulmonary Disease in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 32 - 39. [Abstract] [Full Text] [PDF]

				A Lokke, P Lange, H Scharling, P Fabricius, and J Vestbo Developing COPD: a 25 year follow up study of the general population. Thorax, November 1, 2006; 61(11): 935 - 939. [Abstract] [Full Text] [PDF]

				N. Stenfors Physician-Diagnosed COPD Global Initiative for Chronic Obstructive Lung Disease Stage IV in Ostersund, Sweden: Patient Characteristics and Estimated Prevalence. Chest, September 1, 2006; 130(3): 666 - 671. [Abstract] [Full Text] [PDF]

				D. M. Mannino GOLD Stage 0 COPD: Is it Real? Does it Matter? Chest, August 1, 2006; 130(2): 309 - 310. [Full Text] [PDF]

				K. Stavem, L. Sandvik, and J. Erikssen Can Global Initiative for Chronic Obstructive Lung Disease Stage 0 Provide Prognostic Information on Long-term Mortality in Men? Chest, August 1, 2006; 130(2): 318 - 325. [Abstract] [Full Text] [PDF]

				F. Guddo, A. M. Vignola, M. Saetta, S. Baraldo, L. Siena, E. Balestro, R. Zuin, A. Papi, P. Maestrelli, L. M. Fabbri, et al. Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Eur. Respir. J., May 1, 2006; 27(5): 957 - 963. [Abstract] [Full Text] [PDF]

				A. Lindberg, B. Eriksson, L.-G. Larsson, E. Ronmark, T. Sandstrom, and B. Lundback Seven-Year Cumulative Incidence of COPD in an Age-Stratified General Population Sample. Chest, April 1, 2006; 129(4): 879 - 885. [Abstract] [Full Text] [PDF]

				J Vestbo and J C Hogg Convergence of the epidemiology and pathology of COPD Thorax, January 1, 2006; 61(1): 86 - 88. [Abstract] [Full Text] [PDF]

				W. MacNee Pathogenesis of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 258 - 266. [Abstract] [Full Text] [PDF]

				P. K. Henneberger, A.-C. Olin, E. Andersson, S. Hagberg, and K. Toren The Incidence of Respiratory Symptoms and Diseases Among Pulp Mill Workers With Peak Exposures to Ozone and Other Irritant Gases Chest, October 1, 2005; 128(4): 3028 - 3037. [Abstract] [Full Text] [PDF]

				A Johannessen, E R Omenaas, P S Bakke, and A Gulsvik Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study Thorax, October 1, 2005; 60(10): 842 - 847. [Abstract] [Full Text] [PDF]

				J J Egan, F J Martinez, A U Wells, and T Williams Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification Thorax, April 1, 2005; 60(4): 270 - 273. [Full Text] [PDF]

				G. Viegi, G. Matteelli, A. Angino, A. Scognamiglio, S. Baldacci, J. B. Soriano, and L. Carrozzi The Proportional Venn Diagram of Obstructive Lung Disease in the Italian General Population Chest, October 1, 2004; 126(4): 1093 - 1101. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley The GOLD Classification Has Advanced Understanding of COPD Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 211 - 212. [Full Text] [PDF]

				H. A. M. Kerstjens The GOLD Classification Has Not Advanced Understanding of COPD Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 212 - 213. [Full Text] [PDF]

				J Vestbo Chronic bronchitis: should it worry us? Chronic Respiratory Disease, July 1, 2004; 1(3): 173 - 176. [Abstract] [PDF]

				E. R. Sutherland and R. M. Cherniack Management of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., June 24, 2004; 350(26): 2689 - 2697. [Full Text] [PDF]

				P.J. Sterk Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1 Eur. Respir. J., April 1, 2004; 23(4): 497 - 498. [Full Text] [PDF]

				J Vestbo COPD in the ECRHS Thorax, February 1, 2004; 59(2): 89 - 90. [Full Text] [PDF]

				R de Marco, S Accordini, I Cerveri, A Corsico, J Sunyer, F Neukirch, N Kunzli, B Leynaert, C Janson, T Gislason, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages Thorax, February 1, 2004; 59(2): 120 - 125. [Abstract] [Full Text] [PDF]

				P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellularmechanisms Eur. Respir. J., October 1, 2003; 22(4): 672 - 688. [Abstract] [Full Text] [PDF]

				I. Cerveri, S. Accordini, A. Corsico, M.C. Zoia, L. Carrozzi, L. Cazzoletti, M. Beccaria, A. Marinoni, G. Viegi, and R. de Marco Chronic cough and phlegm in young adults Eur. Respir. J., September 1, 2003; 22(3): 413 - 417. [Abstract] [Full Text] [PDF]

				The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1S - 44s. [Full Text] [PDF]

				D. Stanescu Identifying Smokers at Risk of COPD and GOLD Am. J. Respir. Crit. Care Med., August 15, 2003; 168(4): 500 - 500. [Full Text]

				S.T. Weiss, D.L. DeMeo, and D.S. Postma COPD: problems in diagnosis and measurement Eur. Respir. J., June 1, 2003; 21(41_suppl): 4S - 12s. [Abstract] [Full Text] [PDF]

				I. Cerveri, A. Corsico, M. C. Zoia, J. Vestbo, and P. Lange Gold Stage 0 Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 936 - 936. [Full Text] [PDF]

				M. J. Tobin Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370. [Full Text] [PDF]